Severe Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI